Caraway Therapeutics

1 follower


Caraway’s therapeutic approach leverages genetic data and unique biological understanding to develop proprietary small molecules that activate cellular clearance and recycling processes – accelerating clearance of accumulated toxic materials and defective cellular components.

Industries

Employees

11-50

Links


Org chart

Magdalene Moran
President & Chief Scientific Officer
Rhonda M. Chicko
Chief Financial Officer
Jeff Packman
Chief Development Officer
Jayhong Chong
Senior Director

Board & advisors

Tim Harris
Chair, Scientific Advisory Board
Ivan Dikic
Co-Founder & Scientific Advisor
Wade Harper
Co-Founder & Scientific Advisor
John Lowe
Scientific Advisor
John McCall
Scientific Advisor
Kalpana Merchant
Scientific Advisor
Amy Ripka
Scientific Advisor
Bernardo Sabatini
Scientific Advisor
James B. Summers
Scientific Advisor
David E. Clapham
Scientific Advisor

Teams


Offices